These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31523829)

  • 21. Are complex DCE-MRI models supported by clinical data?
    Duan C; Kallehauge JF; Bretthorst GL; Tanderup K; Ackerman JJ; Garbow JR
    Magn Reson Med; 2017 Mar; 77(3):1329-1339. PubMed ID: 26946317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicystic mucinous adenocarcinoma of the uterine cervix compared with benign multicystic lesions: Multiparametric MR features.
    Song J; Hu Q; Huang J; Ma Z; Chen T
    J Magn Reson Imaging; 2018 Nov; 48(5):1336-1343. PubMed ID: 29624774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.
    Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC
    Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved repeatability of dynamic contrast-enhanced MRI using the complex MRI signal to derive arterial input functions: a test-retest study in prostate cancer patients.
    Klawer EME; van Houdt PJ; Simonis FFJ; van den Berg CAT; Pos FJ; Heijmink SWTPJ; Isebaert S; Haustermans K; van der Heide UA
    Magn Reson Med; 2019 May; 81(5):3358-3369. PubMed ID: 30656738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perfusion-sensitive parameters of intravoxel incoherent motion MRI in rectal cancer: evaluation of reproducibility and correlation with dynamic contrast-enhanced MRI.
    Yang X; Xiao X; Lu B; Chen Y; Wen Z; Yu S
    Acta Radiol; 2019 May; 60(5):569-577. PubMed ID: 30114928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benign or Malignant Characterization of Soft-Tissue Tumors by Using Semiquantitative and Quantitative Parameters of Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Zhang Y; Yue B; Zhao X; Chen H; Sun L; Zhang X; Hao D
    Can Assoc Radiol J; 2020 Feb; 71(1):92-99. PubMed ID: 32062994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI.
    Gity M; Parviz S; Saligheh Rad H; Fathi Kazerooni A; Shirali E; Shakiba M; Baikpour M
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1073-1079. PubMed ID: 31030476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA; Cutajar M; Gordon I
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiomic features of Pk-DCE MRI parameters based on the extensive Tofts model in application of breast cancer.
    Zhou X; Gao F; Duan S; Zhang L; Liu Y; Zhou J; Bai G; Tao W
    Phys Eng Sci Med; 2020 Jun; 43(2):517-524. PubMed ID: 32524436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality-based pharmacokinetic model selection on DCE-MRI for characterizing orbital lesions.
    Lecler A; Balvay D; Cuenod CA; Marais L; Zmuda M; Sadik JC; Galatoire O; Farah E; El Methni J; Zuber K; Bergès O; Savatovsky J; Fournier L
    J Magn Reson Imaging; 2019 Nov; 50(5):1514-1525. PubMed ID: 30989761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dependence of DCE-MRI biomarker values on analysis algorithm.
    Ng CS; Wei W; Bankson JA; Ravoori MK; Han L; Brammer DW; Klumpp S; Waterton JC; Jackson EF
    PLoS One; 2015; 10(7):e0130168. PubMed ID: 26208254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
    Hectors SJ; Besa C; Wagner M; Jajamovich GH; Haines GK; Lewis S; Tewari A; Rastinehad A; Huang W; Taouli B
    J Magn Reson Imaging; 2017 Sep; 46(3):837-849. PubMed ID: 28092414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tracer kinetic models as temporal constraints during brain tumor DCE-MRI reconstruction.
    Lingala SG; Guo Y; Bliesener Y; Zhu Y; Lebel RM; Law M; Nayak KS
    Med Phys; 2020 Jan; 47(1):37-51. PubMed ID: 31663134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histogram analysis parameters identify multiple associations between DWI and DCE MRI in head and neck squamous cell carcinoma.
    Meyer HJ; Leifels L; Schob S; Garnov N; Surov A
    Magn Reson Imaging; 2018 Jan; 45():72-77. PubMed ID: 28963049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Making the invisible visible: improving detectability of MRI-invisible residual cervical cancer after conisation by DCE-MRI.
    Huang JW; Song JC; Chen T; Yang M; Ma ZL
    Clin Radiol; 2019 Feb; 74(2):166.e15-166.e21. PubMed ID: 30503642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging.
    Ahn SS; Shin NY; Chang JH; Kim SH; Kim EH; Kim DW; Lee SK
    J Neurosurg; 2014 Aug; 121(2):367-73. PubMed ID: 24949678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation of High-Grade from Low-Grade Astrocytoma: Improvement in Diagnostic Accuracy and Reliability of Pharmacokinetic Parameters from DCE MR Imaging by Using Arterial Input Functions Obtained from DSC MR Imaging.
    You SH; Choi SH; Kim TM; Park CK; Park SH; Won JK; Kim IH; Lee ST; Choi HJ; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
    Radiology; 2018 Mar; 286(3):981-991. PubMed ID: 29244617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of DCE-MRI parameters for brain tumors through implementation of physiologically-based pharmacokinetic model approaches for Gd-DOTA.
    Spanakis M; Kontopodis E; Van Cauter S; Sakkalis V; Marias K
    J Pharmacokinet Pharmacodyn; 2016 Oct; 43(5):529-47. PubMed ID: 27647272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Operator dependency of arterial input function in dynamic contrast-enhanced MRI.
    Kleppestø M; Bjørnerud A; Groote IR; Kim M; Vardal J; Larsson C
    MAGMA; 2022 Feb; 35(1):105-112. PubMed ID: 34213687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.